6AVN
Crystal structure of unbound anti-HIV antibody Fab PGV19 at 2.5 A
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 23-ID-B |
Synchrotron site | APS |
Beamline | 23-ID-B |
Temperature [K] | 293 |
Detector technology | PIXEL |
Collection date | 2014-08-09 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 1.000 |
Spacegroup name | P 43 21 2 |
Unit cell lengths | 69.783, 69.783, 193.280 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 49.344 - 2.500 |
R-factor | 0.2012 |
Rwork | 0.199 |
R-free | 0.24960 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4lsu |
RMSD bond length | 0.002 |
RMSD bond angle | 0.556 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX ((1.12_2829: 000)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.540 |
High resolution limit [Å] | 2.500 | 2.500 |
Number of reflections | 17498 | 837 |
<I/σ(I)> | 13.2 | |
Completeness [%] | 100.0 | 100 |
Redundancy | 7.8 | 7.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293.15 | 10% (v/v) glycerol, 0.1 M ammonium sulfate, 0.1 M HEPES (pH 7.5), 5% (w/v) PEG 3000 and 30% (v/v) PEG 400 |